Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial

PaperCitations, authors & open-access status

Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 341 citations, 2019 year and hybrid oa status.

341
Citations
2019
Year
hybrid
OA Status

Related on ScholarIQ

Xue Li
Author
Annals of the Rheumatic Diseases
Journal
Systemic Lupus Erythematosus Research
Topic
Systemic Lupus Erythematosus Research
Topic
Cytomegalovirus and herpesvirus research
Topic
T-cell and B-cell Immunology
Topic
470M+ articles · free account